Blog

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

Certara2021 年 6 月 25 日

Blog

This is the first of three blog posts discussing best practices for developing oligonucleotides. Interest…

Certara2021 年 5 月 7 日

On-Demand Webinar

The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…

Certara2021 年 4 月 29 日

Case Study

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

Certara2021 年 2 月 12 日

Blog

By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…

Certara2021 年 2 月 1 日

生物制剂